Media and Newsroom

ProUroCare Medical Inc. To Delist From The OTCQB And Deregister Its Common Stock, Units and Warrants[03/12/2014]

ProUroCare Announces Changes to Management and Board of Directors [04/19/13]

Dr. Michael Chambers Elected Chairman of ProUroCare Board of Directors [11/30/2012]

ProUroCare Submits Cleaning and Disinfection Protocol to FDA for Review [11/30/2012]

ProUroCare Names Consultant to Head New Technology and Product Development Activities [08/01/2012]

ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System [05/01/12]

ProUroCare Medical Announces Election of Larry W. Getlin to Board [07/07/11]

ProUroCare Medical Announces $3 Million Financing Agreement [09/29/10]

ProUroCare Medical Announces Completion of Warrant Replacement Offering [08/05/10]

ProUroCare In the Media

 

ProUroCare Announces New Board of Directors Member

ProUroCare Medical Inc
September 9, 2013
ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of David Kaysen as a member of its Board of Directors effective September 9, 2013. From May 2006 until April 2013, Mr. Kaysen was President, CEO and a director of Uroplasty, Inc. a Nasdaq listed medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. From July 2005 to May 2006, Mr. Kaysen served as President, CEO and a director of Advanced Duplication Services, LLC, a privately-held replicator and duplicator of optical media. Between December 2002 and June 2005, he served as President, CEO and a director of Diametrics Medical, Inc., then a publicly-traded manufacturer and marketer of critical blood analysis systems that provided continuous diagnostic results at point of patient care. From 1992 to 2002, Mr. Kaysen served as President, CEO and a director of Rehabilicare Inc., then a publicly-traded manufacturer and marketer of electromedical rehabilitation and pain management products for clinician, home and industrial use.

Jim Davis, Chairman of the Board of Directors stated "Mr. Kaysen's broad and extensive experience as an executive officer of publicly traded medical device companies in a wide variety of specialties, as a director of public companies, and as a sales manager of multi-national medical companies will be very beneficial to the future growth of the company".

About ProUroCare Medical Inc.
ProUroCare Medical Inc. is a publicly traded company engaged in the business of creating innovative medical imaging products. The company’s ProUroScan system, an elasticity imaging technology used to document abnormalities of the prostate previously detected by a digital rectal examination, received commercial clearance from the FDA in April 2012. Based in Minneapolis, the company’s stock trades on the OTCQB market (www.otcmarkets.com).

Eden Prairie Firm Wins Approval to Sell Prostate Imaging Technology

Minneapolis Star Tribune
May 27, 2012
CEO Rick Carlson and Director Larry Getlin are interviewed in this article about the FDA approval of the ProUroScan prostate imaging system.
http://www.startribune.com/business/154232585.html

FDA Clears ProUroCare’s New Prostate Mechanical Imaging System

News-Medical.Net
May 2, 2012
An article that appeared on News-Medical.net concerning FDA approval of the ProUroScan.
http://www.news-medical.net/news/20120502/FDA-clears-ProUroCaree28099s-new-prostate-mechanical-imaging-system.aspx

FDA Approves Device That was Developed in the Twin Cities

KSTP TV, Minneapolis
May 2, 2012
From KSTP's evening news, a discussion of the ProUroScan's approval and what it means for prostate disease patients.
http://kstp.com/news/stories/S2604752.shtml?cat=1

ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System

DeviceSpace.com
May 1, 2012
An article that appeared on DeviceSpace.Com concerning FDA approval of the ProUroScan.
http://www.devicespace.com/news_story.aspx?StoryID=258244&full=1

Prostate Cancer is a Manageable Disease

Arizona Republic
September 25, 2009
CEO Rick Carlson and Dr. Robert Weiss are quoted in this article about managing prostate cancer and detection options which also mentions the ProUroScan system.
http://www.azcentral.com/community/scottsdale/articles/2009/09/25/20090925aging0925.html

Media Contacts

Aaron Berstler, Kohnstamm Communications, 651.789.1264

Rick Carlson, CEO, 952.698.1160

Press Kit

Press kit fact sheets:

ProUroScan(TM)

Prostate Disease Detection Options